The White House on Thursday announced that it has finalized negotiations with the manufacturers of the 10 drugs selected for the first round of drug price negotiation under the Biden Administration’s Inflation Reduction Act of 2022 (IRA), which the Administration said will save $1.5 billion in out-of-pocket costs for prescription drugs for people on Medicare and will save Medicare $6 billion “in the first year alone.”
Recent Posts
- Other Barks & Bites for Friday, June 6: UK House of Lords Insists on Copyright Transparency in AI Bill; OpenAI Vows to Appeal New York Times Ruling; and Stewart Sua Sponte Orders Review of PTAB Win for TikTok
- Squires’ Responses to Senate Judiciary Committee Focus on Balance, Backlog and ‘Born Strong’ Patents
- USPTO Study into Applications with Large Patent Families Raises Questions
- Agency’s Acting Deputy Director Says It’s Back to Basics for the USPTO
- Quantum Computers and the Evolution of AI | IPWatchdog Unleashed